NRA-MONTELUKAST

nora pharma inc🇨🇦 Health Canada

Approval Id: aa52e11ed7cd9bd6
Drug Approval Canada Name: NRA-MONTELUKAST
Product Name: NRA-MONTELUKAST
Status: Marketed
Status Date: 2024-06-10
Original Market Date: 2019-12-28
Din: 02489821
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 48:10.24
Atc Original: R03DC03 MONTELUKAST
Atc Name: r 03 dc 03
Aig Number: 0133823002
Company Name: nora pharma inc
Company Address: 1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7

MONTELUKAST (MONTELUKAST SODIUM)

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

aa52e11ed7cd9bd6

Type

Standard